NPCE

insider transactions

NeuroPace Inc — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

Net shares · 365d

-25.0K

0 buy · 25.0K sell

Net value · 365d

-$399.2K

$0 in · $399.2K out

Sentiment · 365d

Net selling

0% buying · 100% selling

Open-market trades · 365d

0 buy · 25.0K sell

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Grant·A
Jun 5, 26

Renee Ryan

Director

$0

5.4K sh

Own New
Grant·A
Jun 5, 26

Renee Ryan

Director

$0

2.9K sh

Own New
Grant·A
Jun 5, 26

Rakhi Kumar

Director

$0

5.4K sh

Own New
Grant·A
Jun 5, 26

Rakhi Kumar

Director

$0

2.9K sh

Own +15%
Grant·A
Jun 5, 26

Uri Geiger

Director

$0

5.4K sh

Own New
Grant·A
Jun 5, 26

Uri Geiger

Director

$0

2.9K sh

Own +19%
Grant·A
Jun 5, 26

Frank M Fischer

Director

$0

5.4K sh

Own New
Grant·A
Jun 5, 26

Frank M Fischer

Director

$0

2.9K sh

Own +0%
Grant·A
Jun 5, 26

Lisa Andrade

Director

$0

5.4K sh

Own New
Grant·A
Jun 5, 26

Lisa Andrade

Director

$0

2.9K sh

Own New
Other·F
Jun 3, 26

Joel Becker KEY

CHIEF EXECUTIVE OFFICER

$19.9K

1.3K sh · $15.88

Own -1%
Other·F
May 27, 26

Martha Morrell

CHIEF MEDICAL OFFICER

$6.1K

358 sh · $17.06

Own -1%
Other·F
May 27, 26

Joel Becker KEY

CHIEF EXECUTIVE OFFICER

$19.2K

1.1K sh · $17.06

Own -1%
Grant·A
May 15, 26

Patrick F. Williams KEY

Chief Financial Officer

$0

44.8K sh

Own New
Grant·A
May 15, 26

Patrick F. Williams KEY

Chief Financial Officer

$0

16.8K sh

Own +32%
Grant·A
May 15, 26

Martha Morrell

CHIEF MEDICAL OFFICER

$0

14.6K sh

Own New
Grant·A
May 15, 26

Martha Morrell

CHIEF MEDICAL OFFICER

$0

5.5K sh

Own +12%
Grant·A
May 15, 26

Joel Becker KEY

CHIEF EXECUTIVE OFFICER

$0

122.2K sh

Own New
Grant·A
May 15, 26

Joel Becker KEY

CHIEF EXECUTIVE OFFICER

$0

45.9K sh

Own +47%
Other·F
Mar 24, 26

Martha Morrell

CHIEF MEDICAL OFFICER

$17.8K

1.3K sh · $13.27

Own -3%
Grant·A
Mar 20, 26

Rakhi Kumar

Director

$15.0K

1.2K sh · $13.00

Own +6%
Grant·A
Mar 20, 26

Frank M Fischer

Director

$23.7K

1.8K sh · $13.00

Own +0%
Grant·A
Mar 20, 26

Joseph Lacob

Director

$11.2K

865 sh · $13.00

Own +6%
Grant·A
Mar 20, 26

Uri Geiger

Director

$11.9K

913 sh · $13.00

Own +7%
Other·F
Mar 3, 26

Martha Morrell

CHIEF MEDICAL OFFICER

$18.5K

1.3K sh · $13.83

Own -3%
Other·F
Mar 3, 26

Joel Becker KEY

CHIEF EXECUTIVE OFFICER

$69.5K

5.0K sh · $13.83

Own -5%
Other·F
Feb 27, 26

Martha Morrell

CHIEF MEDICAL OFFICER

$5.2K

358 sh · $14.58

Own -0%
Other·F
Feb 27, 26

Joel Becker KEY

CHIEF EXECUTIVE OFFICER

$16.4K

1.1K sh · $14.58

Own -1%
Other·F
Feb 20, 26

Martha Morrell

CHIEF MEDICAL OFFICER

$48.9K

3.4K sh · $14.34

Own -4%
Sell·S
Dec 15, 25

Martha Morrell

CHIEF MEDICAL OFFICER

$399.2K

25.0K sh · $15.97

Own -33%

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
Jun 5, 2026	Renee Ryan	Director	Grant A	5.4K	New	—	$0
Jun 5, 2026	Renee Ryan	Director	Grant A	2.9K	New	—	$0
Jun 5, 2026	Rakhi Kumar	Director	Grant A	5.4K	New	—	$0
Jun 5, 2026	Rakhi Kumar	Director	Grant A	2.9K	+15%	—	$0
Jun 5, 2026	Uri Geiger	Director	Grant A	5.4K	New	—	$0
Jun 5, 2026	Uri Geiger	Director	Grant A	2.9K	+19%	—	$0
Jun 5, 2026	Frank M Fischer	Director	Grant A	5.4K	New	—	$0
Jun 5, 2026	Frank M Fischer	Director	Grant A	2.9K	+0%	—	$0
Jun 5, 2026	Lisa Andrade	Director	Grant A	5.4K	New	—	$0
Jun 5, 2026	Lisa Andrade	Director	Grant A	2.9K	New	—	$0
Jun 3, 2026	Joel Becker KEY	CHIEF EXECUTIVE OFFICER	Other F	1.3K	-1%	$15.88	$19.9K
May 27, 2026	Martha Morrell	CHIEF MEDICAL OFFICER	Other F	358	-1%	$17.06	$6.1K
May 27, 2026	Joel Becker KEY	CHIEF EXECUTIVE OFFICER	Other F	1.1K	-1%	$17.06	$19.2K
May 15, 2026	Patrick F. Williams KEY	Chief Financial Officer	Grant A	44.8K	New	—	$0
May 15, 2026	Patrick F. Williams KEY	Chief Financial Officer	Grant A	16.8K	+32%	—	$0
May 15, 2026	Martha Morrell	CHIEF MEDICAL OFFICER	Grant A	14.6K	New	—	$0
May 15, 2026	Martha Morrell	CHIEF MEDICAL OFFICER	Grant A	5.5K	+12%	—	$0
May 15, 2026	Joel Becker KEY	CHIEF EXECUTIVE OFFICER	Grant A	122.2K	New	—	$0
May 15, 2026	Joel Becker KEY	CHIEF EXECUTIVE OFFICER	Grant A	45.9K	+47%	—	$0
Mar 24, 2026	Martha Morrell	CHIEF MEDICAL OFFICER	Other F	1.3K	-3%	$13.27	$17.8K
Mar 20, 2026	Rakhi Kumar	Director	Grant A	1.2K	+6%	$13.00	$15.0K
Mar 20, 2026	Frank M Fischer	Director	Grant A	1.8K	+0%	$13.00	$23.7K
Mar 20, 2026	Joseph Lacob	Director	Grant A	865	+6%	$13.00	$11.2K
Mar 20, 2026	Uri Geiger	Director	Grant A	913	+7%	$13.00	$11.9K
Mar 3, 2026	Martha Morrell	CHIEF MEDICAL OFFICER	Other F	1.3K	-3%	$13.83	$18.5K
Mar 3, 2026	Joel Becker KEY	CHIEF EXECUTIVE OFFICER	Other F	5.0K	-5%	$13.83	$69.5K
Feb 27, 2026	Martha Morrell	CHIEF MEDICAL OFFICER	Other F	358	-0%	$14.58	$5.2K
Feb 27, 2026	Joel Becker KEY	CHIEF EXECUTIVE OFFICER	Other F	1.1K	-1%	$14.58	$16.4K
Feb 20, 2026	Martha Morrell	CHIEF MEDICAL OFFICER	Other F	3.4K	-4%	$14.34	$48.9K
Dec 15, 2025	Martha Morrell	CHIEF MEDICAL OFFICER	Sell S	25.0K	-33%	$15.97	$399.2K

About NPCE insider trading

This page tracks insider transactions for NeuroPace Inc (NPCE) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.